Wockhardt Plans Big Product Launch In U.S., European Expansion
This article was originally published in PharmAsia News
India's Wockhardt said it plans to launch as many as 15 products in the United States during the current fiscal year and expand its presence in Europe
You may also be interested in...
Diabetes-care company Bigfoot Biomedical announced it raised $55m in a Series C round to support US FDA submission for its insulin delivery system.
Firm supplying all-in-one multivitamin blends rather than packs of multiple pills has four-member advisory board including digital marketing and consumer product marketing specialists and a health care strategist.
UK-headquartered company gets further backing from Novo Ventures and other investors convinced of the potential of NLRP3 inhibitors.